Published in Women's Health Weekly, September 6th, 2001
Those differences show up in comparisons between lymph node evaluations of micrometastases or macrometastases, according to Nancy Klauber-DeMore and coworkers at Memorial Sloan-Kettering Cancer Center in New York City.
"Clinically undetectable micrometastases may account for disease recurrence in breast cancer patients after variable disease-free intervals," Klaber-DeMore and coworkers said in a report on the new research.
To understand how growth patterns evolve in patients with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly